Six decades of struggle over The Pill


In mid-1957 the US Food and Drug Administration approved the drug Enovid as a treatment for menstrual disturbance. It went on to approve its use as a contraceptive in 1960, after studies indicated the drug’s safety and efficacy.

An editorial in Nature this week catalogues the tumultuous history of the first oral contraceptive since 1957, celebrating its wide availability today. Once a social taboo, the article reports that in 2015 the contraceptive-drug market was worth more than US$6.1 billion globally. And a 2015 UN report stated that approximately 9% of women worldwide used The Pill.

The editors suggest that The Pill has been associated with increased enrollments in college for younger women, as well as an increase in average income. Margaret Sanger, they reflect, “maybe...would be celebrating” despite the “lack of political will” to make contraceptives more available in developing countries.

The anniversary comes at an interesting time, as Catholics prepare to mark the 50th anniversary of the papal encyclical Humanae Vitae in 2018. Humanae Vitae (1968) deemed artificial contraception to be against both natural ethics and Christian morality, and has provided a strong counterpoint to the near universal endorsement of contraception within North America and Europe.




MORE ON THESE TOPICS | birth control, catholic church, contraception, the pill

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed


 Best of the web
 
comments powered by Disqus